Tiansheng Pharmaceutical Group Co Ltd Capital Reinvestment Ratio
Tiansheng Pharmaceutical Group Co Ltd capital reinvestment ratio. Tiansheng Pharmaceutical Group Co Ltd (002872) has a Capital Reinvestment Ratio of 0.30x as of March 2025, meaning it reinvests 0% of its operating cash flow (CN¥31.79 Million) in capital expenditures (CN¥9.44 Million). Check 002872 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Tiansheng Pharmaceutical Group Co Ltd (2012–2024)
Capital reinvestment ratio of Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024. This chart tracks Tiansheng Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Also explore Tiansheng Pharmaceutical Group Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Tiansheng Pharmaceutical Group Co Ltd Capital Reinvestment Ratio by Year (2012–2024)
Tiansheng Pharmaceutical Group Co Ltd capital reinvestment ratio by year from 2012 to 2024. For the full cash flow conversion analysis, see 002872 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.00x | CN¥50.15 Million | CN¥50.27 Million | ▲ +21.8% |
| 2022 | 0.82x | CN¥89.18 Million | CN¥73.42 Million | ▼ -86.3% |
| 2021 | 6.03x | CN¥18.97 Million | CN¥114.38 Million | ▲ +1134.1% |
| 2020 | 0.49x | CN¥189.75 Million | CN¥92.70 Million | ▼ -24.4% |
| 2019 | 0.65x | CN¥144.21 Million | CN¥93.24 Million | ▼ -57.5% |
| 2018 | 1.52x | CN¥153.99 Million | CN¥234.27 Million | ▲ +81.0% |
| 2016 | 0.84x | CN¥506.68 Million | CN¥425.96 Million | ▼ -34.7% |
| 2015 | 1.29x | CN¥213.54 Million | CN¥274.87 Million | ▼ -25.2% |
| 2014 | 1.72x | CN¥191.99 Million | CN¥330.32 Million | ▼ -22.3% |
| 2013 | 2.21x | CN¥57.06 Million | CN¥126.34 Million | ▲ +74.0% |
| 2012 | 1.27x | CN¥145.06 Million | CN¥184.63 Million | — |